Adetunji TL, Olisah C, Acho MA, Oyetunde-Joshua F, Amoo SO. Global research trends and recent advances in medicinal plant-synthesized nanoparticles for cancer treatment. Plants [Internet]. 2024;13:2836.
Google Scholar
Hayat R, Manzoor M, Hussain A. Wnt signaling pathway: a comprehensive review. Cell Biol Int [Internet]. 2022;46:863–77.
Google Scholar
Guo R, Xing QS. Roles of Wnt signaling pathway and ROR2 receptor in embryonic development: an update review article. Epigenet Insights [Internet]. 2022 Jan [cited 2025 Jan 31];15. Available from: https://journals.sagepub.com/doi/full/10.1177/25168657211064232
Wang H, Chen K, Zong L, Zhao X, Wang J, Fan S, et al. MALAT1/miR-7-5p/TCF4 axis regulating menstrual blood mesenchymal stem cells improve thin endometrium fertility by the Wnt signaling pathway. Cell Transpl [Internet]. 2024 Jan 1 [cited 2025 Jan 31];33. Available from: https://journals.sagepub.com/doi/full/10.1177/09636897241259552
Hu L, Chen W, Qian A, Li YP. Wnt/β-catenin signaling components and mechanisms in bone formation, homeostasis, and disease. Bone Res. 2024;12:1–33.
Google Scholar
Ben-Ghedalia-Peled N, Vago R. Wnt signaling in the development of bone metastasis. Cells. 2022;11:3934.
Google Scholar
Huang C, Ma R, Xu Y, Li N, Li Z, Yue J, et al. Wnt2 promotes non-small cell lung cancer progression by activating WNT/β-catenin pathway. Am J Cancer Res [Internet]. 2015;5:1032.
Google Scholar
Yang F, Zeng Q, Yu G, Li S, Wang CY. Wnt/β-catenin signaling inhibits death receptor-mediated apoptosis and promotes invasive growth of HNSCC. Cell Signal. 2006;18:679–87.
Google Scholar
Widelitz R. Wnt signaling through canonical and non-canonical pathways: Recent progress. Growth Factors [Internet]. 2005;23:111–6.
Google Scholar
Liu J, Xiao Q, Xiao J, Niu C, Li Y, Zhang X, et al. Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities. Signal Transduct Target Ther. 2021;7:1–23.
Davidson G. LRPs in WNT signalling. Handb Exp Pharm [Internet]. 2021;269:45–73.
Google Scholar
Chen Q, Suzuki K, Sifuentes-Dominguez L, Miyata N, Song J, Lopez A, et al. Paneth cell–derived growth factors support tumorigenesis in the small intestine. Life Sci Alliance [Internet]. 2021 Mar [cited 2025 Dec 20];4. Available from: https://www.life-science-alliance.org/content/4/3/e202000934
van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, Hatzis P, et al. Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol [Internet]. 2005;7:381–6.
Google Scholar
Flanagan DJ, Austin CR, Vincan E, Phesse TJ. Wnt signalling in gastrointestinal epithelial stem cells. Genes. 2018;9:178.
Google Scholar
Nalapareddy K, Nattamai KJ, Kumar RS, Karns R, Wikenheiser-Brokamp KA, Sampson LL, et al. Canonical Wnt Signaling Ameliorates Aging of Intestinal Stem Cells. Cell Rep [Internet]. 2017;18:2608–21.
Google Scholar
Song P, Gao Z, Bao Y, Chen L, Huang Y, Liu Y, et al. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol 2024 [Internet]. 2024;17:1–30.
Google Scholar
Peri SS, Narayanaa YK, Hubert TD, Rajaraman R, Arfuso F, Sundaram S, et al. Navigating tumour microenvironment and Wnt signalling crosstalk: implications for advanced cancer therapeutics. Cancers (Basel) [Internet]. 2023;15:584 .
Duchartre Y, Kim YM, Kahn M. The Wnt signaling pathway in cancer. Crit Rev Oncol Hematol [Internet]. 2015;99:141.
Google Scholar
Hankey W, Frankel WL, Groden J. Functions of the APC tumor suppressor protein dependent and independent of canonical WNT signaling: implications for therapeutic targeting. Cancer Metastasis Rev [Internet]. 2018;37:159.
Google Scholar
Martínez-Gil N, Ugartondo N, Grinberg D, Balcells S. Wnt pathway extracellular components and their essential roles in bone homeostasis. Genes (Basel) [Internet]. 2022;13:138.
Google Scholar
Ljungberg JK, Kling JC, Tran TT, Blumenthal A. Functions of the WNT signaling network in shaping host responses to infection. Front Immunol [Internet]. 2019;10:482213.
Pinto D, Gregorieff A, Begthel H, Clevers H. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev [Internet]. 2003;17:1709–13.
Google Scholar
Fevr T, Robine S, Louvard D, Huelsken J. Wnt/β-catenin is essential for intestinal homeostasis and maintenance of intestinal stem cells. Mol Cell Biol [Internet]. 2007;27:7551–9.
Google Scholar
Smith NR, Giske NR, Sengupta SK, Conley P, Swain JR, Nair A, et al. Dual states of murine Bmi1-expressing intestinal stem cells drive epithelial development utilizing non-canonical Wnt signaling. Dev Cell [Internet]. 2025;60:2177–2191.e5 .
Google Scholar
Stamos JL, Weis WI. The β-catenin destruction complex. Cold Spring Harb Perspect Biol [Internet]. 2013;5:a00789 .
MacDonald BT, Tamai K, He X. Wnt/β-catenin signaling: components, mechanisms, and diseases. Dev Cell [Internet]. 2009;17:9.
Google Scholar
MacDonald BT, He X. Frizzled and LRP5/6 receptors for Wnt/β-catenin signaling. Cold Spring Harb Perspect Biol [Internet]. 2012;4:a007880.
Google Scholar
Schaefer KN, Pronobis MI, Williams CE, Zhang S, Bauer L, Goldfarb D, et al. Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex. Mol Biol Cell [Internet]. 2020 May [cited 2025 Mar 6];31:992. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC7346726/
Li VSW, Ng SS, Boersema PJ, Low TY, Karthaus WR, Gerlach JP, et al. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell [Internet]. 2012;149:1245–56.
Google Scholar
Shang S, Hua F, Hu ZW, Shang S, Hua F, Hu ZW. The regulation of β-catenin activity and function in cancer: therapeutic opportunities. Oncotarget [Internet]. 2017;8:33972–89.
Google Scholar
Valenta T, Hausmann G, Basler K. The many faces and functions of β-catenin. EMBO J [Internet]. 2012;31:2714.
Google Scholar
Yu F, Yu C, Li F, Zuo Y, Wang Y, Yao L, et al. Wnt/β-catenin signaling in cancers and targeted therapies. Signal Transduct Target Ther. 2021;6:1–24.
Google Scholar
Harb J, Lin PJ, Hao J. Recent development of Wnt signaling pathway inhibitors for cancer therapeutics. Curr Oncol Rep [Internet]. 2019;21:1–9.
Chen Y, Chen Z, Tang Y, Xiao Q. The involvement of noncanonical Wnt signaling in cancers. Biomed Pharmacother. 2021;133:110946.
Google Scholar
Vladar EK, Königshoff M. Noncanonical Wnt planar cell polarity signaling in lung development and disease. Biochem Soc Trans [Internet]. 2020;48:23 .
Patni AP, Harishankar MK, Joseph JP, Sreeshma B, Jayaraj R, Devi A. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma – clinical implications. Cell Oncol. 2021;44:473–94.
Google Scholar
VanderVorst K, Dreyer CA, Konopelski SE, Lee H, Ho HYH, Carraway KL. Wnt/PCP signaling contribution to carcinoma collective cell migration and metastasis. Cancer Res [Internet]. 2019;79:1719–29.
Google Scholar
Kühl M, Sheldahl LC, Malbon CC, Moon RT. Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem [Internet]. 2000;275:12701–11.
Google Scholar
Uehara S, Udagawa N, Kobayashi Y. Non-canonical Wnt signals regulate cytoskeletal remodeling in osteoclasts. Cell Mol Life Sci [Internet]. 2018;75:368 .
Qin K, Yu M, Fan J, Wang H, Zhao P, Zhao G, et al. Canonical and noncanonical Wnt signaling: Multilayered mediators, signaling mechanisms and major signaling crosstalk. Genes Dis [Internet]. 2024;11:103–34.
Google Scholar
Asem MS, Buechler S, Wates RB, Miller DL, Stack MS. Wnt5a Signaling in Cancer. Cancers. 2016;8:79 .
Google Scholar
Parsons MJ, Tammela T, Dow LE. WNT as a driver and dependency in cancer. Cancer Discov [Internet]. 2021 Oct 1 [cited 2025 Mar 6];11:2413. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC8487948/
Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev. 2021;169:118–36.
Google Scholar
Liu D, Chen L, Zhao H, Vaziri ND, Ma SC, Zhao YY. Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy. Biomed Pharmacother. 2019;117:108990.
Google Scholar
Kumar KK, Burgess AW, Gulbis JM. Structure and function of LGR5: An enigmatic G-protein coupled receptor marking stem cells. Protein Sci [Internet]. 2014;23:551.
Google Scholar
Meng F, Liu X, Lin C, Xu L, Liu J, Zhang P, et al. SMYD2 suppresses APC2 expression to activate the Wnt/β-catenin pathway and promotes epithelial-mesenchymal transition in colorectal cancer. Am J Cancer Res [Internet]. 2020;10:997.
Google Scholar
Liu Y, Zhao C, Wang G, Chen J, Ju S, Huang J, et al. SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer. Cell Death Discov [Internet]. 2022 Dec [cited 2025 Mar 6];8:200. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC9010412/
Miao Z, Zhao X, Liu X. Hypoxia induced β-catenin lactylation promotes the cell proliferation and stemness of colorectal cancer through the wnt signaling pathway. Exp Cell Res [Internet]. 2023 Jan [cited 2025 Sep 26];422. Available from: https://pubmed.ncbi.nlm.nih.gov/36464122/
Zhou K, Cheong JE, Krishnaji ST, Ghalali A, Fu H, Sui L, et al. Inhibition of Wnt signaling in colon cancer cells via an oral drug that facilitates TNIK degradation. Mol Cancer Ther [Internet]. 2023;22:25–36.
Google Scholar
de Lau W, Peng WC, Gros P, Clevers H. The R-spondin/Lgr5/Rnf43 module: regulator of Wnt signal strength. Genes Dev [Internet]. 2014;28:305–16.
Google Scholar
Li X, Chen W, Huang L, Zhu M, Zhang H, Si Y, et al. Sinomenine hydrochloride suppresses the stemness of breast cancer stem cells by inhibiting Wnt signaling pathway through down-regulation of WNT10B. Pharmacol Res [Internet]. 2022 May [cited 2025 Mar 6];179. Available from: https://pubmed.ncbi.nlm.nih.gov/35413424/
Ye X, Cen Y, Li Q, Zhang YP, Li Q, Li J. Immunosuppressive SOX9-AS1 resists triple-negative breast cancer senescence via regulating Wnt signalling pathway. J Cell Mol Med [Internet]. 2024;28:e70208.
Google Scholar
Liang Z, Liu L, Gao R, Che C, Yang G. Downregulation of exosomal miR-7-5p promotes breast cancer migration and invasion by targeting RYK and participating in the atypical WNT signalling pathway. Cell Mol Biol Lett [Internet]. 2022;27:88.
Google Scholar
Lager TW, Conner C, Keating CR, Warshaw JN, Panopoulos AD. Cell surface GRP78 and Dermcidin cooperate to regulate breast cancer cell migration through Wnt signaling. Oncogene [Internet]. 2021;40:4050.
Google Scholar
Zhang S, Guo L, Zhang Z, Liu X, Chen W, Wei Y, et al. Type-I protein arginine methyltransferase inhibition primes anti-programmed cell death protein 1 immunotherapy in triple-negative breast cancer. Cancer [Internet]. 2024;130:1415–23.
Google Scholar
Nagaraj AB, Knarr M, Sekhar S, Connor RS, Joseph P, Kovalenko O, et al. The miR-181a-SFRP4 axis regulates Wnt activation to drive stemness and platinum resistance in ovarian cancer. Cancer Res [Internet]. 2021;81:2044.
Google Scholar
Hu W, Li M, Chen Y, Gu X. UBE2S promotes the progression and Olaparib resistance of ovarian cancer through Wnt/β-catenin signaling pathway. J Ovarian Res [Internet]. 2021;14:121.
Google Scholar
Shalev N, Kendall M, Anil SM, Tiwari S, Peeri H, Kumar N, et al. Phytocannabinoid compositions from cannabis act synergistically with PARP1 inhibitor against ovarian cancer cells in vitro and affect the Wnt signaling pathway. Molecules [Internet]. 2022;27:7523.
Google Scholar
Wang L, Wang J, Yin X, Guan X, Li Y, Xin C, et al. GIPC2 interacts with Fzd7 to promote prostate cancer metastasis by activating WNT signaling. Oncogene. 2022;41:2609–23.
Google Scholar
Ma F, Arai S, Wang K, Calagua C, Yuan AR, Poluben L, et al. Autocrine canonical Wnt signaling primes noncanonical signaling through ROR1 in metastatic castration-resistant prostate cancer. Cancer Res [Internet]. 2022;82:1518.
Google Scholar
Yong X, Tang B, Xiao YF, Xie R, Qin Y, Luo G, et al. Helicobacter pylori upregulates Nanog and Oct4 via Wnt/β-catenin signaling pathway to promote cancer stem cell-like properties in human gastric cancer. Cancer Lett [Internet]. 2016;374:292–303.
Google Scholar
Tian S, Peng P, Li J, Deng H, Zhan N, Zeng Z, et al. SERPINH1 regulates EMT and gastric cancer metastasis via the Wnt/β-catenin signaling pathway. Aging [Internet]. 2020;12:3574–93.
Google Scholar
Wu H, Xu H, Jia D, Li T, Xia L. METTL3-induced UCK2 m6A hypermethylation promotes melanoma cancer cell metastasis via the WNT/β-catenin pathway. Ann Transl Med [Internet]. 2021;9:1155–1155.
Google Scholar
Hirata H, Ueno K, Nakajima K, Tabatabai ZL, Hinoda Y, Ishii N, et al. Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells. Br J Cancer [Internet]. 2013;108:2070–8.
Google Scholar
Zhai H, Zhao J, Pu J, Zhao P, Wei J. LncRNA-DUXAP8 regulation of the Wnt/β-catenin signaling pathway to inhibit glycolysis and induced apoptosis in acute myeloid leukemia. Turk J Hematol [Internet]. 2021;38:264–72.
Google Scholar
Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W, et al. N6-methyladenosine–mediated up-regulation of FZD10 regulates liver cancer stem cells’ properties and lenvatinib resistance through WNT/β-catenin and hippo signaling pathways. Gastroenterol [Internet]. 2023;164:990–1005.
Google Scholar
Jiang H chao, Gao Y, Wang S yan, Zhao Y lan, Sun H peng. Overexpressed Wnt-7a acts as a potential antitumor immune modulator and predicts poor prognosis in HNSCC. Heliyon. 2025;11:e42794.
Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med [Internet]. 2013;19:1423.
Google Scholar
de Visser KE, Joyce JA. The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth. Cancer Cell. 2023;41:374–403.
Google Scholar
Neophytou CM, Panagi M, Stylianopoulos T, Papageorgis P. The role of tumor microenvironment in cancer metastasis: molecular mechanisms and therapeutic opportunities. Cancers (Basel) [Internet]. 2021;13:2053.
Google Scholar
Qin X, Li T, Li S, Yang H, Wu C, Zheng C, et al. The tumor biochemical and biophysical microenvironments synergistically contribute to cancer cell malignancy. Cell Mol Immunol [Internet]. 2020;17:1186–7.
Google Scholar
Wang K, Qiu X, Zhao Y, Wang H, Chen L. The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma. Cancer Biol Med [Internet]. 2022;19:305–18.
Google Scholar
Louault K, Li RR, Declerck YA. Cancer-associated fibroblasts: understanding their heterogeneity. Cancers (Basel) [Internet]. 2020;12:1–28.
Mhaidly R, Mechta-Grigoriou F. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies. Semin Immunol. 2020;48:101417.
Google Scholar
Lv K, He T. Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets. Mol Biomedicine [Internet]. 2024;5:70.
Google Scholar
Radisky ES. Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis. J Biol Chem [Internet]. 2024;300:107347.
Google Scholar
Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, et al. Targeting cytokine and chemokine signaling pathways for cancer therapy. Signal Transduct Target Ther. 2024;9:1–48.
Qi Y, Wang H, Zhang Q, Liu Z, Wang T, Wu Z, et al. CAF-released exosomal miR-20a-5p facilitates HCC progression via the LIMA1-mediated β-catenin pathway. Cells [Internet]. 2022;11:3857.
Google Scholar
Yao L, Zhou C, Liu L, He J, Wang Y, Wang A. Cancer-associated fibroblasts promote growth and dissemination of esophageal squamous cell carcinoma cells by secreting WNT family member 5A. Mol Cell Biochem [Internet]. 2025 [cited 2025 Apr 5]; Available from: https://pubmed.ncbi.nlm.nih.gov/39954174/
Fang Y, Xiao X, Wang J, Dasari S, Pepin D, Nephew KP, et al. Cancer associated fibroblasts serve as an ovarian cancer stem cell niche through noncanonical Wnt5a signaling. NPJ Precis Oncol [Internet]. 2024;8:7.
Google Scholar
Yuan Y, Wu D, Hou Y, Zhang Y, Tan C, Nie X, et al. Wnt signaling: Modulating tumor-associated macrophages and related immunotherapeutic insights. Biochem Pharm [Internet]. 2024;223:116154.
Google Scholar
Ge Z, Ding S. The crosstalk between tumor-associated macrophages (TAMs) and tumor cells and the corresponding targeted therapy. Front Oncol [Internet]. 2020;10:590941.
Google Scholar
Han ZP, Liu DB, Wu LQ, Li Q, Wang ZG, Zang XF. IL-1β secreted by macrophage M2 promotes metastasis of osteosarcoma via NF-κB/miR-181α-5p/RASSF1A/Wnt pathway. Transl Cancer Res [Internet]. 2020;9:2721.
Google Scholar
Wang WG, Chen SJ, He JS, Li JS, Zang XF. The tumor suppressive role of RASSF1A in osteosarcoma through the Wnt signaling pathway. Tumour Biol [Internet]. 2016;37:8869–77.
Google Scholar
Wang L, Zhang L, Zhao L, Shao S, Ning Q, Jing X, et al. VEGFA/NRP-1/GAPVD1 axis promotes progression and cancer stemness of triple-negative breast cancer by enhancing tumor cell-macrophage crosstalk. Int J Biol Sci [Internet]. 2024;20:446–63.
Google Scholar
Fan Z, Ye M, Liu D, Zhou W, Zeng T, He S, et al. Lactate drives the ESM1–SCD1 axis to inhibit the antitumor CD8+T-cell response by activating the Wnt/β-catenin pathway in ovarian cancer cells and inducing cisplatin resistance. Int Immunopharmacol [Internet]. 2024 Aug [cited 2025 Apr 5];137. Available from: https://www.researchgate.net/publication/381577078_Lactate_drives_the_ESM1-SCD1_axis_to_inhibit_the_antitumor_CD8_T-cell_response_by_activating_the_Wntb-catenin_pathway_in_ovarian_cancer_cells_and_inducing_cisplatin_resistance
Qian Y, Yin Y, Zheng X, Liu Z, Wang X. Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities. Biomark Res [Internet]. 2024;12:1.
Google Scholar
Hu A, Sun L, Lin H, Liao Y, Yang H, Mao Y. Harnessing innate immune pathways for therapeutic advancement in cancer. Signal Transduct Target Ther. 2024;9:1–59.
Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH. The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharm. 2023;949:175586.
Google Scholar
Leone P, Malerba E, Susca N, Favoino E, Perosa F, Brunori G, et al. Endothelial cells in tumor microenvironment: insights and perspectives. Front Immunol [Internet]. 2024;15:1367875.
Google Scholar
Fang J, Lu Y, Zheng J, Jiang X, Shen H, Shang X, et al. Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications. Cell Death Dis. 2023;14:1–15.
Google Scholar
Lv F, Li X, Wang Y, Hao L. MAGP1 maintains tumorigenicity and angiogenesis of laryngeal cancer by activating Wnt/β-catenin/MMP7 pathway. Carcinogenesis [Internet]. 2024;45:220–34.
Google Scholar
Olsen JJ, Pohl S, Öther G, Deshmukh A, Visweswaran M, Ward NC, Arfuso F, et al. The role of Wnt signalling in angiogenesis. Clin Biochem Rev [Internet]. 2017;38:131.
Google Scholar
Emami Nejad A, Najafgholian S, Rostami A, Sistani A, Shojaeifar S, Esparvarinha M, et al. The role of hypoxia in the tumor microenvironment and development of cancer stem cell: a novel approach to developing treatment. Cancer Cell Int [Internet]. 2021;21:62.
Google Scholar
Kane K, Edwards D, Chen J. The influence of endothelial metabolic reprogramming on the tumor microenvironment. Oncogene [Internet]. 2024;44:51.
Google Scholar
Estephan LE, Kumar G, Stewart M, Banoub R, Linnenbach A, Harshyne LA, et al. Altered extracellular matrix correlates with an immunosuppressive tumor microenvironment and disease progression in younger adults with oral cavity squamous cell carcinoma. Front Oncol [Internet]. 2024 [cited 2025 Apr 2];14. Available from: https://pubmed.ncbi.nlm.nih.gov/38957320/
Lee JJ, Ng KY, Bakhtiar A. Extracellular matrix: unlocking new avenues in cancer treatment. Biomark Res [Internet]. 2025;13:78.
Google Scholar
Si H, Zhao N, Pedroza A, Rosen JM, Creighton CJ, Roarty K. Non-canonical Wnt/Ror2 signaling status regulates cell-matrix crosstalk to prompt directional tumor cell invasion and dissemination in breast cancer. bioRxiv [Internet]. 2021 May [cited 2025 Sep 8];2021.05.15.444295. Available from: https://www.biorxiv.org/content/10.1101/2021.05.15.444295v1
Patras L, Paul D, Matei IR. Weaving the nest: extracellular matrix roles in pre-metastatic niche formation. Front Oncol [Internet]. 2023 [cited 2025 Sep 8];13:1163786. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC10282420/
Nishida N, Rodríguez M. Role of oncogenic pathways on the cancer immunosuppressive microenvironment and its clinical implications in hepatocellular carcinoma. Cancers (Basel) [Internet]. 2021;13:3666.
Google Scholar
Ruan Y, Ogana H, Gang E, Kim HN, Kim YM. Wnt signaling in the tumor microenvironment. Adv Exp Med Biol [Internet]. 2021;1270:107–21.
Google Scholar
Wörthmüller J, Rüegg C. The crosstalk between FAK and Wnt signaling pathways in cancer and its therapeutic implication. Int J Mol Sci [Internet]. 2020;21:1–23.
Park WJ, Kim MJ. A new wave of targeting “Undruggable” Wnt signaling for cancer therapy: challenges and opportunities. Cells [Internet]. 2023 Apr [cited 2025 Apr 5];12. Available from: https://pubmed.ncbi.nlm.nih.gov/37190019/
Sethakorn N, Heninger E, Breneman MT, Recchia E, Ding AB, Jarrard DF, et al. Integrated analysis of the tumor microenvironment using a reconfigurable microfluidic cell culture platform. FASEB J [Internet]. 2022 Oct [cited 2025 Apr 5];36. Available from: https://pubmed.ncbi.nlm.nih.gov/36083096/
Plesselova S, Calar K, Axemaker H, Sahly E, de la Puente P. Multicompartmentalized microvascularized tumor-on-a-chip to study tumor-stroma interactions and drug resistance in ovarian cancer. bioRxiv [Internet]. 2024 Jun 2 [cited 2025 Apr 5]; Available from: https://pubmed.ncbi.nlm.nih.gov/38853974/
Tufail M, Jiang CH, Li N. Wnt signaling in cancer: from biomarkers to targeted therapies and clinical translation. Mol Cancer [Internet]. 2025;24:107.
Google Scholar
Mustachio LM, Chelariu-Raicu A, Szekvolgyi L, Roszik J. Targeting KRAS in cancer: promising therapeutic strategies. Cancers (Basel) [Internet]. 2021;13:1204.
Google Scholar
Phillips C, Bhamra I, Eagle C, Flanagan E, Armer R, Jones CD, et al. The Wnt pathway inhibitor RXC004 blocks tumor growth and reverses immune evasion in Wnt ligand-dependent cancer models. Cancer Res Commun [Internet]. 2022;2:914–28.
Google Scholar
Tang Y, Jiang M, Chen A, Qu W, Han X, Zuo J, et al. Porcupine inhibitor LGK-974 inhibits Wnt/β-catenin signaling and modifies tumor-associated macrophages resulting in inhibition of the malignant behaviors of non-small cell lung cancer cells. Mol Med Rep [Internet]. 2021;24:550.
Google Scholar
Jimeno A, Gordon M, Chugh R, Messersmith W, Mendelson D, Dupont J, et al. A first-in-human phase I study of the anticancer stem cell agent ipafricept (OMP-54F28), a decoy receptor for Wnt ligands, in patients with advanced solid tumors. Clin Cancer Res [Internet]. 2017;23:7490–7.
Google Scholar
Diamond JR, Becerra C, Richards D, Mita A, Osborne C, O’Shaughnessy J, et al. Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer. Breast Cancer Res Treat [Internet]. 2020;184:53 .
Google Scholar
McGonigle S, Chen Z, Wu J, Chang P, Kolber-Simonds D, Ackermann K, et al. E7449: A dual inhibitor of PARP1/2 and tankyrase1/2 inhibits growth of DNA repair deficient tumors and antagonizes Wnt signaling. Oncotarget [Internet]. 2015;6:41307–23.
Google Scholar
Osawa Y, Oboki K, Imamura J, Kojika E, Hayashi Y, Hishima T, et al. Inhibition of cyclic adenosine monophosphate (cAMP)-response element-binding protein (CREB)-binding protein (CBP)/β-catenin reduces liver fibrosis in mice. EBioMedicine. 2015;2:1751–8.
Google Scholar
Salik B, Yi H, Hassan N, Santiappillai N, Vick B, Connerty P, et al. Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia. Cancer Cell [Internet]. 2020;38:263–278.e6.
Google Scholar
Sun Q, Wang Y, Fu Q, Ouyang A, Liu S, Wang Z, et al. Sulfur-coordinated organoiridium(III) complexes exert breast anticancer activity via inhibition of Wnt/β-catenin signaling. Angew Chem Int Ed Engl [Internet]. 2021;60:4841–8.
Google Scholar
Giannakis M, Le DT, Pishvaian MJ, Weinberg BA, Papadopoulos KP, Shen L, et al. Phase 1 study of WNT pathway Porcupine inhibitor CGX1321 and phase 1b study of CGX1321 + pembrolizumab (pembro) in patients (pts) with advanced gastrointestinal (GI) tumors. J Clin Oncol [Internet]. 2023;41:3514–3514.
Google Scholar
Anderson NM, Simon MC. Tumor microenvironment. Curr Biol [Internet]. 2020;30:R921.
Google Scholar
Jiang W, Guan B, Sun H, Mi Y, Cai S, Wan R, et al. WNT11 Promotes immune evasion and resistance to Anti-PD-1 therapy in liver metastasis. Nat Commun [Internet]. 2025;16:1429.
Google Scholar
Thiele S, Zimmer A, Göbel A, Rachner TD, Rother S, Fuessel S, et al. Role of WNT5A receptors FZD5 and RYK in prostate cancer cells. Oncotarget [Internet]. 2018;9:27293.
Google Scholar
Wang Y, He L, Du Y, Zhu P, Huang G, Luo J, et al. The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling. Cell Stem Cell [Internet]. 2015;16:413–25.
Google Scholar
Zhang Y, Zhu X, Chen L, Gao T, Chen G, Zhu J, et al. β-Catenin mediated TAM phenotype promotes pancreatic cancer metastasis via the OSM/STAT3/LOXL2 axis. Neoplasia [Internet]. 2024 Feb [cited 2025 Sep 2];60:101096. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC11745814/
Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, et al. APC mutations occur early during colorectal tumorigenesis. Nat [Internet]. 1992;359:235–7.
Google Scholar
Korinek V, Barker N, Morin PJ, Van Wichen D, De Weger R, Kinzler KW, et al. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC(-/-) colon carcinoma. Sci (1979) [Internet]. 1997;275:1784–7.
Google Scholar
Choi AR, Park JR, Kim RJ, Kim SR, Cho SD, Jung JY, et al. Inhibition of Wnt1 expression reduces the enrichment of cancer stem cells in a mouse model of breast cancer. Biochem Biophys Res Commun [Internet]. 2012;425:436–42.
Google Scholar
Yang L, Wu X, Wang Y, Zhang K, Wu J, Yuan YC, et al. FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene. 2011;30:4437–46.
Google Scholar
Liu CC, Prior J, Piwnica-Worms D, Bu G. LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy. Proc Natl Acad Sci USA [Internet]. 2010;107:5136–41.
Google Scholar
Lu C, Wang X, Zhu H, Feng J, Ni S, Huang J, et al. Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer. Oncotarget [Internet]. 2015;6:24912–21.
Google Scholar
Wrona A, Sejda A, Dziadziuszko R, Jassem J. Prognostic significance of Wnt1, Wnt2, E-cadherin, and β-catenin expression in Operable non-small cell lung cancer. J Histochem Cytochem [Internet]. 2021;69:711–22.
Google Scholar
Anastas JN, Kulikauskas RM, Tamir T, Rizos H, Long GV, Von Euw EM, et al. WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors. J Clin Invest [Internet]. 2014;124:2877–90.
Google Scholar
Wronski N, Madej E, Grabacka M, Brożyna AA, Wolnicka-Glubisz A. RIPK4 downregulation impairs Wnt3A-stimulated invasiveness via Wnt/β-catenin signaling in melanoma cells and tumor growth in vivo. Cell Signal [Internet]. 2024;113:110938.
Google Scholar
Kaplan Z, Zielske SP, Ibrahim KG, Cackowski FC. Wnt and β-catenin signaling in the bone metastasis of prostate cancer. Life. 2021;11:1099.
Google Scholar
Lee E, Madar A, David G, Garabedian MJ, Gupta R Das, Logan SK. Inhibition of androgen receptor and β-catenin activity in prostate cancer. Proc Natl Acad Sci USA [Internet]. 2013 Sep [cited 2025 Sep 2];110:15710–5. Available from: https://pmc.ncbi.nlm.nih.gov/articles/PMC3785716/
Takada T, Yagi Y, Maekita T, Imura M, Nakagawa S, Tsao SW, et al. Methylation-associated silencing of the Wnt antagonist SFRP1 gene in human ovarian cancers. Cancer Sci [Internet]. 2005;95:741.
Google Scholar
Yoshioka S, King ML, Ran S, Okuda H, MacLean JA, McAsey ME, et al. WNT7A regulates tumor growth and progression in ovarian cancer through the WNT/β-catenin pathway. Mol Cancer Res [Internet]. 2012;10:469–82.
Google Scholar
Zhang W, Yan Y, Gu M, Wang X, Zhu H, Zhang S, et al. High expression levels of Wnt5a and Ror2 in laryngeal squamous cell carcinoma are associated with poor prognosis. Oncol Lett [Internet]. 2017;14:2232.
Google Scholar
Gao H, Li L, Xiao M, Guo Y, Shen Y, Cheng L, et al. Elevated DKK1 expression is an independent unfavorable prognostic indicator of survival in head and neck squamous cell carcinoma. Cancer Manag Res [Internet]. 2018;10:5083.
Google Scholar
Xie J, Huang L, Lu YG, Zheng DL. Roles of the Wnt signaling pathway in head and neck squamous cell carcinoma. Front Mol Biosci [Internet]. 2021 Jan [cited 2025 Sep 2];7:590912. Available from: www.frontiersin.org
